ArticleHemaSphere2024

Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade.

Denis M Schewe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.